Cours Mabvax Therapeutics Holdings Inc Other OTC
Actions
US55414P7024
Recherche biotechnologique et médicale
CA 2016 | 148 k 132 k | CA 2017 | - | Capitalisation | 14,41 M 12,85 M |
---|---|---|---|---|---|
Résultat net 2016 | -17 M -15,16 M | Résultat net 2017 | -19 M -16,94 M | VE / CA 2016 | 147 x |
Dette nette 2016 | 470 k 419 k | Dette nette 2017 | 2,48 M 2,21 M | VE / CA 2017 | - |
PER 2016 |
-0,93
x | PER 2017 |
-0,25
x | Employés | - |
Rendement 2016 * |
-
| Rendement 2017 |
-
| Flottant | 92,02% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Chief Executive Officer | 72 | - | |
Chief Tech/Sci/R&D Officer | 81 | 08/07/14 | |
Paul W. Maffuid
CTO | Chief Tech/Sci/R&D Officer | 68 | 08/07/14 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Chief Tech/Sci/R&D Officer | 81 | 08/07/14 |
Varia. 1 janv. | Capi. | |
---|---|---|
+15,85% | 122 Md | |
+18,91% | 113 Md | |
+7,31% | 22,84 Md | |
-18,63% | 20,72 Md | |
-13,76% | 16,39 Md | |
-16,15% | 16,51 Md | |
-43,53% | 15,83 Md | |
+1,75% | 13,49 Md | |
+28,07% | 11,67 Md |